The visit aims to deepen collaboration between India and Egypt and explore new opportunities for joint ventures, technology transfer, and capacity-building across the healthcare and pharmaceutical industries. The delegation includes senior representatives from India’s pharmaceutical industry and is focused on opportunities in generics, biosimilars, and vaccines—areas in which India has established global leadership. Egypt’s pharmaceutical market, projected to grow from $5.1bn in 2024-25 to $5.7bn in 2025-26, presents significant potential for strategic partnerships and investment. Ambassador Reddy highlighted the growing momentum in India-Egypt pharmaceutical relations, stating: “India has long been a trusted partner in the global pharmaceutical industry, and Egypt’s dynamic healthcare sector offers an ideal platform for deeper collaboration. The visit also marks the launch of new initiatives designed to stimulate investment, promote knowledge exchange, and drive innovation in the healthcare sector.

Source: Daily News Egypt January 11, 2026 22:34 UTC